These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 12487627)

  • 1. Characterization of Streptococcus pneumoniae enoyl-(acyl-carrier protein) reductase (FabK).
    Marrakchi H; Dewolf WE; Quinn C; West J; Polizzi BJ; So CY; Holmes DJ; Reed SL; Heath RJ; Payne DJ; Rock CO; Wallis NG
    Biochem J; 2003 Mar; 370(Pt 3):1055-62. PubMed ID: 12487627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atromentin and leucomelone, the first inhibitors specific to enoyl-ACP reductase (FabK) of Streptococcus pneumoniae.
    Zheng CJ; Sohn MJ; Kim WG
    J Antibiot (Tokyo); 2006 Dec; 59(12):808-12. PubMed ID: 17323650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The enoyl-[acyl-carrier-protein] reductase (FabI) of Escherichia coli, which catalyzes a key regulatory step in fatty acid biosynthesis, accepts NADH and NADPH as cofactors and is inhibited by palmitoyl-CoA.
    Bergler H; Fuchsbichler S; Högenauer G; Turnowsky F
    Eur J Biochem; 1996 Dec; 242(3):689-94. PubMed ID: 9022698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylimidazole derivatives of 4-pyridone as dual inhibitors of bacterial enoyl-acyl carrier protein reductases FabI and FabK.
    Kitagawa H; Ozawa T; Takahata S; Iida M; Saito J; Yamada M
    J Med Chem; 2007 Sep; 50(19):4710-20. PubMed ID: 17713898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of enoyl-acyl carrier protein reductase (FabK) from Streptococcus pneumoniae reveals the binding mode of an inhibitor.
    Saito J; Yamada M; Watanabe T; Iida M; Kitagawa H; Takahata S; Ozawa T; Takeuchi Y; Ohsawa F
    Protein Sci; 2008 Apr; 17(4):691-9. PubMed ID: 18305197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vibrio cholerae FabV defines a new class of enoyl-acyl carrier protein reductase.
    Massengo-Tiassé RP; Cronan JE
    J Biol Chem; 2008 Jan; 283(3):1308-1316. PubMed ID: 18032386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Pseudomonas aeruginosa enoyl-acyl carrier protein reductase (FabI): a target for the antimicrobial triclosan and its role in acylated homoserine lactone synthesis.
    Hoang TT; Schweizer HP
    J Bacteriol; 1999 Sep; 181(17):5489-97. PubMed ID: 10464225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenylimidazole derivatives as specific inhibitors of bacterial enoyl-acyl carrier protein reductase FabK.
    Ozawa T; Kitagawa H; Yamamoto Y; Takahata S; Iida M; Osaki Y; Yamada K
    Bioorg Med Chem; 2007 Dec; 15(23):7325-36. PubMed ID: 17892940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unsaturated fatty acid synthesis in Enterococcus faecalis requires a specific enoyl-ACP reductase.
    Dong H; Cronan JE
    Mol Microbiol; 2022 Nov; 118(5):541-551. PubMed ID: 36100979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis.
    Heath RJ; Su N; Murphy CK; Rock CO
    J Biol Chem; 2000 Dec; 275(51):40128-33. PubMed ID: 11007778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The two functional enoyl-acyl carrier protein reductases of Enterococcus faecalis do not mediate triclosan resistance.
    Zhu L; Bi H; Ma J; Hu Z; Zhang W; Cronan JE; Wang H
    mBio; 2013 Oct; 4(5):e00613-13. PubMed ID: 24085780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystallization and preliminary X-ray analysis of enoyl-acyl carrier protein reductase (FabK) from Streptococcus pneumoniae.
    Saito J; Yamada M; Watanabe T; Kitagawa H; Takeuchi Y
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Jun; 62(Pt 6):576-8. PubMed ID: 16754986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enoyl-acyl carrier protein reductase (fabI) plays a determinant role in completing cycles of fatty acid elongation in Escherichia coli.
    Heath RJ; Rock CO
    J Biol Chem; 1995 Nov; 270(44):26538-42. PubMed ID: 7592873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabK.
    Seefeld MA; Miller WH; Newlander KA; Burgess WJ; DeWolf WE; Elkins PA; Head MS; Jakas DR; Janson CA; Keller PM; Manley PJ; Moore TD; Payne DJ; Pearson S; Polizzi BJ; Qiu X; Rittenhouse SF; Uzinskas IN; Wallis NG; Huffman WF
    J Med Chem; 2003 Apr; 46(9):1627-35. PubMed ID: 12699381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AG205, a novel agent directed against FabK of Streptococcus pneumoniae.
    Takahata S; Iida M; Osaki Y; Saito J; Kitagawa H; Ozawa T; Yoshida T; Hoshiko S
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2869-71. PubMed ID: 16870790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural characterization of Porphyromonas gingivalis enoyl-ACP reductase II (FabK).
    Hevener KE; Santarsiero BD; Lee H; Jones JA; Boci T; Johnson ME; Mehboob S
    Acta Crystallogr F Struct Biol Commun; 2018 Feb; 74(Pt 2):105-112. PubMed ID: 29400320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inefficient translation renders the Enterococcus faecalis fabK enoyl-acyl carrier protein reductase phenotypically cryptic.
    Bi H; Zhu L; Wang H; Cronan JE
    J Bacteriol; 2014 Jan; 196(1):170-9. PubMed ID: 24163335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of a hybrid genetic system to study the functional relationship between prokaryotic and plant multi-enzyme fatty acid synthetase complexes.
    Kater MM; Koningstein GM; Nijkamp HJ; Stuitje AR
    Plant Mol Biol; 1994 Aug; 25(5):771-90. PubMed ID: 8075395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylimidazole derivatives as new inhibitors of bacterial enoyl-ACP reductase FabK.
    Kitagawa H; Ozawa T; Takahata S; Iida M
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4982-6. PubMed ID: 17600706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein EnvM is the NADH-dependent enoyl-ACP reductase (FabI) of Escherichia coli.
    Bergler H; Wallner P; Ebeling A; Leitinger B; Fuchsbichler S; Aschauer H; Kollenz G; Högenauer G; Turnowsky F
    J Biol Chem; 1994 Feb; 269(8):5493-6. PubMed ID: 8119879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.